71°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Readers' Choice

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

0.7263 -0.0179 (-2.41%)

Delayed Quote Updated: 9:55 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

37 38 Next >

Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022 ↗

August 23, 2022

Via Benzinga

Where Ocugen Stands With Analysts ↗

August 23, 2022

Analysts have provided the following ratings for Ocugen (NASDAQ:OCGN) within the last quarter:

Via Benzinga

This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says ↗

August 23, 2022

Via Benzinga

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Outlook For Ocugen ↗

August 04, 2022

Ocugen (NASDAQ:OCGN) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Ocugen will report an...

Via Benzinga

Ocugen's Partner COVID-19 Vaccine Covaxin Shows Encouraging Action In Children Below 18 Years ↗

June 21, 2022

Via Benzinga

Ocugen Diversifies Its Pipeline With New Cell Therapy Platform ↗

May 24, 2022

Via Benzinga

OCGN Stock Falls Despite Positive FDA Update ↗

May 23, 2022

Shares of the biotech company are falling despite news that the FDA has cleared it to resume clinical trials of its Covid-19 vaccine.

Via InvestorPlace

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial ↗

May 23, 2022

Via Benzinga

The Top Reasons to Avoid the Ocugen Stock ↗

April 28, 2022

WIth Ocugen, there’s nothing to get excited about here. Avoid the OCGN stock, as it heads significantly lower.

Via InvestorPlace

Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial ↗

April 25, 2022

Via Benzinga

Why Ocugen Shares Are Trading Higher Today ↗

April 18, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 15, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

7 Stocks to Short Before July 2022 ↗

June 15, 2022

There are many highly overvalued publicly traded companies that will have trouble staying afloat, giving investors many stocks to short.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2022 ↗

June 02, 2022

Via Benzinga

Why Is Ocugen (OCGN) Stock Down Today? ↗

April 12, 2022

Shares of OCGN stock are trading lower after the FDA announced that it had placed a clinical hold on Covaxin. Here's what you should know.

Via InvestorPlace

FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial ↗

April 12, 2022

The

Via Benzinga

Here's Why Ocugen Shares Are Falling ↗

April 12, 2022

Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 5.86% to $2.73 during Tuesday's pre-market session after the company announced that it was informed by the FDA that...

Via Benzinga

Earnings Scheduled For May 6, 2022 ↗

May 06, 2022

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.

Via Benzinga

What the WHO Snub Means For Ocugen Stock Investors? ↗

April 04, 2022

Add the World Health Organization's suspension of Covaxin to the list of troubles that are weighing down OCGN stock.

Via InvestorPlace

Why Is Ocugen (OCGN) Stock Up 10% Today? ↗

March 17, 2022

Sometimes, improved investor sentiment and a revamped website is enough of a catalyst to take something like OCGN stock on a 10% ride higher.

Via InvestorPlace

Novavax Stock Could Give Back More of Its Pandemic-Era Gains ↗

April 22, 2022

While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium.

Via InvestorPlace

State Street Just Bought Ocugen (OCGN) Stock. Here’s Why. ↗

April 14, 2022

OCGN stock has declined by over 90% in the past five years. However, that hasn't stopped State Street from more than doubling its position.

Via InvestorPlace

Why Is Lixte Biotechnology (LIXT) Stock Up Today? ↗

April 12, 2022

Lixte Biotechnology (LIXT) stock is rocketing higher on Tuesday after the company revealed pre-clinical results for one of its treatments.

Via InvestorPlace

Read Why Did WHO Suspend UN Supply of Bharat Biotech's Covaxin COVID-19 Vaccine ↗

April 04, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 04, 2022

If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today.

Via InvestorPlace

26 Stocks Moving in Monday's Pre-Market Session ↗

April 04, 2022

Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 million for 2021. Twitter, Inc. (NYSE: TWTR) rose...

Via Benzinga

These Were The 20 Most Searched Tickers On Benzinga In The First Quarter: Did Your Favorite Stock Make The List? ↗

April 03, 2022

The first three months of 2022 are in the books, bringing the first quarter to a close. Investors were faced with many macro events, including rising inflation and the war in Ukraine. Benzinga was a...

Via Benzinga

It’s Time to Get Clinical, Not Cynical, With Ocugen Stock ↗

March 30, 2022

The selling pressure on OCGN stock has been as heavy as a rock, but worried shareholders should celebrate Ocugen's breakthrough moments.

Via InvestorPlace

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Ocugen, Inc. - Common Stock (NQ:OCGN)

All News about Ocugen, Inc. - Common Stock

Sections

Services